3rd CRISPR 2.0 Summit 2022
Evvnt Promotion / evvnt
Archivo
29.11.2022 - 01.12.2022 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 08:30 - 17:00
Temas de la conferencia
Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and innovative delivery platforms.
Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and innovative delivery platforms.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1278515-2?pid=4832
Speakers: Aditya Raguram, PhD Student David Liu Lab, Harvard University, Alexandra Crawley, Co-Founder and Senior Scientist, LifeEDIT, Amy Simon, Chief Medical Officer, Beam Therapeutics, and more.
Brochure: https://go.evvnt.com/1278515-2?pid=4832
Speakers: Aditya Raguram, PhD Student David Liu Lab, Harvard University, Alexandra Crawley, Co-Founder and Senior Scientist, LifeEDIT, Amy Simon, Chief Medical Officer, Beam Therapeutics, and more.
Información e inscripción:
https://go.evvnt.com/1278515-3?pid=4832
Ms. Min Ratcliffe
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
